Dr Luke Grundy

Dr Luke Grundy is a discovery scientist and Head of the NeuroUrology Research Group at Flinders University.

He has spent over a decade uncovering the mechanisms that drive bladder sensation in health and disease, and now leads a multidisciplinary team working with academic, clinical, consumer and industry partners across immunology, microbiology, urology and oncology. His research aims to identify novel therapeutic targets and develop next-generation treatments for bladder pain, including pain associated with cancer therapies.

Dr Grundy has published over 50 peer-reviewed papers and book chapters that have helped to shape emerging therapeutic strategies for bladder pain and improved understanding of cancer-treatment side effects. He is ranked Australia’s leading researcher in bladder pain and among the top 2% of scientists globally . He has attracted competitive funding from the ARC, NHMRC, MRFF, NIH, Flinders Foundation and industry partners, including more than $2 million as Chief Investigator A.

In 2022, he was awarded the Ralph Ernst Fellowship in bladder and prostate cancer, which he used to establish a consumer-led research program into the side effects of bladder cancer treatments in partnership with BEAT Bladder Cancer Australia.

Dr Grundy has been recognised with international young investigator awards from the American Urological Association and has delivered numerous invited presentations nationally and internationally. He also holds national leadership roles, including Board Member and Chair of the Scientific Advisory Committee for ASCEPT (2025–2027).

‍

‍